“…Distinct natriuretic peptide receptors have been identified and characterized by molecular cloning (51,56), which includes natriuretic peptide receptor -A, -B, and -C, also designated, respectively, as NPRA, NPRB, and NPRC (18,37). Both ANP and BNP bind to guanylyl cyclase-A/natriuretic peptide receptor-A (GC-A/NPRA), which is considered to be the principal natriuretic peptide receptor that synthesizes intracellular second messenger cGMP (15,50,65). Mice carrying targeted disruption of the Npr1 gene (encoding for GC-A/NPRA) exhibit hypertension, congestive heart failure, reduced kidney function, and altered plasma renin and angiotensin II (ANG II) levels (47,58,59,65).…”